Antares Pharma, Inc. (AIS) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents
Accounts receivable	8.56M
Inventories	6.72M
Deferred costs	1.96M
Prepaid expenses and other current assets	376.21K
Total current assets	49.41M
Equipment, molds, furniture and fixtures, net	17.99M
Patent rights, net	2.15M
Goodwill	1.1M
Deferred costs
Other assets	153.8K
Total Assets	70.8M
Accounts payable	8.1M
Accrued expenses and other liabilities	6.66M
Deferred revenue	5.8M
Total current liabilities	20.55M
Deferred revenue - long term	1.2M
Total liabilities	21.75M
Preferred Stock: $0.01 par, authorized 3,000,000 shares, none outstanding	0
Common Stock: $0.01 par; authorized 150,000,000 shares; 103,061,099 and 84,157,865 issued and outstanding at June 30, 2011 and December 31, 2010, respectively	1.55M
Additional paid-in capital	297.14M
Accumulated deficit	-248.95M
Accumulated other comprehensive loss	-699.61K
Stockholders' Equity	49.04M
Total Liabilities and Stockholders' Equity	70.8M

Entities mentioned with AIS

View All Entities